Volume 18, Number 1—January 2012
Dispatch
Oral Transmission of L-type Bovine Spongiform Encephalopathy in Primate Model
Table
Inoculation route | L-BSE dose, mg | Inoculated animals |
|||
---|---|---|---|---|---|
No. inoculated (no. alive) | Age at inoculation | Survival after inoculation, mo | Positive for PrPd † | ||
Intracerebral | 5 | 4 | 1 y | 19; 19.5; 22; 22 | 4/4 |
Oral | 50 | 3 (1‡) | 2 mo or 2 y | 18‡; 32 | 2/2 |
Oral | 5 | 5 (2‡) | 2 mo or 2 y | 27; 33; 34 | 2/3 |
*L-BSE, L-type bovine spongiform encephalopathy source; PrPd, disease-associated prion protein. Source of L-BSE, 02–2528.
†Results obtained by Western blot analysis and/or paraffin-embedded tissue-blot analysis and/or immunohistochemical analysis.
‡Animals were inoculated at 2 y of age.
Page created: December 22, 2011
Page updated: December 22, 2011
Page reviewed: December 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.